150 related articles for article (PubMed ID: 7914804)
1. The 2-5A system and HIV infection.
Schröder HC; Kelve M; Müller WE
Prog Mol Subcell Biol; 1994; 14():176-97. PubMed ID: 7914804
[TBL] [Abstract][Full Text] [Related]
2. Photolabeling of the enzymes of the 2-5A synthetase/RNase L/p68 kinase antiviral systems with azido probes.
Suhadolnik RJ
Prog Mol Subcell Biol; 1994; 14():260-75. PubMed ID: 7520331
[No Abstract] [Full Text] [Related]
3. Mechanism of the antiretroviral effect of dsRNA.
Müller WE; Ushijima H; Schröder HC
Prog Mol Subcell Biol; 1994; 14():66-88. PubMed ID: 7914807
[No Abstract] [Full Text] [Related]
4. Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.
Schröder HC; Kelve M; Schäcke H; Pfleiderer W; Charubala R; Suhadolnik RJ; Müller WE
Chem Biol Interact; 1994 Feb; 90(2):169-83. PubMed ID: 8156606
[TBL] [Abstract][Full Text] [Related]
5. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection.
Schröder HC; Suhadolnik RJ; Pfleiderer W; Charubala R; Müller WE
Int J Biochem; 1992; 24(1):55-63. PubMed ID: 1374726
[TBL] [Abstract][Full Text] [Related]
6. 2-5A and virus infection.
Fujii N
Prog Mol Subcell Biol; 1994; 14():150-75. PubMed ID: 8061884
[No Abstract] [Full Text] [Related]
7. Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase.
Ushijima H; Rytik PG; Schäcke H; Scheffer U; Müller WE; Schröder HC
J Interferon Res; 1993 Apr; 13(2):161-71. PubMed ID: 8099601
[TBL] [Abstract][Full Text] [Related]
8. Evidence for age-dependent impairment of antiviral 2',5'-oligoadenylate synthetase/ribonuclease L-system in tissues of rat.
Pfeifer K; Ushijima H; Lorenz B; Müller WE; Schröder HC
Mech Ageing Dev; 1993 Feb; 67(1-2):101-14. PubMed ID: 8469023
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).
Dimitrova DI; Reichenbach NL; Yang X; Pfleiderer W; Charubala R; Gaughan JP; Suh B; Henderson EE; Suhadolnik RJ; Rogers TJ
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):123-34. PubMed ID: 17263642
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.
Suhadolnik RJ; Reichenbach NL; Hitzges P; Sobol RW; Peterson DL; Henry B; Ablashi DV; Müller WE; Schröder HC; Carter WA
Clin Infect Dis; 1994 Jan; 18 Suppl 1():S96-104. PubMed ID: 8148461
[TBL] [Abstract][Full Text] [Related]
11. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.
Ibsen MS; Gad HH; Thavachelvam K; Boesen T; Desprès P; Hartmann R
J Virol; 2014 Dec; 88(24):14222-31. PubMed ID: 25275129
[TBL] [Abstract][Full Text] [Related]
12. The 2-5A system in viral infection and apoptosis.
Castelli J; Wood KA; Youle RJ
Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
[TBL] [Abstract][Full Text] [Related]
13. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
[TBL] [Abstract][Full Text] [Related]
14. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract][Full Text] [Related]
15. High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2'-5'-oligoadenylates.
Morin B; Rabah N; Boretto-Soler J; Tolou H; Alvarez K; Canard B
Antiviral Res; 2010 Sep; 87(3):345-52. PubMed ID: 20547186
[TBL] [Abstract][Full Text] [Related]
16. High levels of 2',5'-oligoadenylate synthetase and 2',5'-oligoadenylate-dependent endonuclease in human trophoblast.
Zhang GY; Beltchev B; Fournier A; Zhang YH; Malassiné A; Bisbal C; Ehresmann B; Ehresmann C; Darlix JL; Thang MN
AIDS Res Hum Retroviruses; 1993 Feb; 9(2):189-96. PubMed ID: 8457385
[TBL] [Abstract][Full Text] [Related]
17. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.
Martinand C; Montavon C; Salehzada T; Silhol M; Lebleu B; Bisbal C
J Virol; 1999 Jan; 73(1):290-6. PubMed ID: 9847332
[TBL] [Abstract][Full Text] [Related]
18. RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.
Madden JC; Cui D; Brinton MA
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462564
[TBL] [Abstract][Full Text] [Related]
19. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity.
Asthana A; Gaughan C; Dong B; Weiss SR; Silverman RH
mBio; 2021 Aug; 12(4):e0178121. PubMed ID: 34372695
[TBL] [Abstract][Full Text] [Related]
20. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
